SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-13-000095
Filing Date
2013-10-16
Accepted
2013-10-15 20:17:36
Documents
5
Period of Report
2013-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xkforatmagreements.htm 8-K 21951
2 EXHIBIT ligand-exhibit51opinionxat.htm EX-5.1 11151
3 EXHIBIT ligand-mlvsalesagreementxa.htm EX-10.1 241941
4 EXHIBIT ligand-brinsonpatricksales.htm EX-10.2 125945
5 latham.jpg GRAPHIC 58875
  Complete submission text file 0000886163-13-000095.txt   483439
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 131153002
SIC: 2834 Pharmaceutical Preparations